デフォルト表紙
市場調査レポート
商品コード
1291421

薬物スクリーニング市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Drug Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 142 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.16円
薬物スクリーニング市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要:

世界の薬物スクリーニングの市場規模は、2022年に60億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に7.6%の成長率(CAGR)を示し、2028年までに98億米ドルに達すると予測しています。麻薬密売人や地元の売人の増加、薬物乱用の増加、仮想通貨の普及などが、市場を牽引する主な要因の一つです。

薬物スクリーニングとは、個人の血液、尿、毛髪、唾液を採取して分析し、薬物使用によって残留した汚染物質や化学物質の存在を検出するプロセスを指します。酵素免疫測定法(IA)、ガスクロマトグラフィー(GC)、液体クロマトグラフィー/質量分析法(LC/MS)など、さまざまな検査方法があり、最初の陽性結果をもとに実施される優れた高精度の薬物確認検査です。コカイン、ヘロイン、3,4-メチレンジオキシメタンフェタミン(MDMA)などの違法薬物を含む薬物の使用や誤用を検出するために使用されます。また、さまざまな処方薬の誤用や大量服用を検出するためにも使用されます。薬物スクリーニングは、様々な新薬の効率と安全性を推定するために、薬物の様々な臨床試験で実施されます。また、薬物スクリーニングは、刑事法の執行を目的とした法的な訴追の際にも実施されます。さらに、オピオイド療法を受けているさまざまな患者の乱用可能性や服薬アドヒアランスを調べる際にも使用されます。

薬物スクリーニングの市場動向:

現在、正確で自然な結果が得られる薬物スクリーニングに対する需要の高まりは、市場にプラスの影響を与える主な要因の1つとなっています。また、世界中で薬物乱用の事例が増加していることも、市場の成長を後押ししています。また、損失、ストレス、不安に対処するために大衆の間で薬物を利用する傾向が強まっており、市場の見通しを良好なものにしています。これとは別に、若い人たちの間で、同調圧力によるクラブ活動、飲酒、喫煙、薬物使用の動向が高まっていることも、市場の成長に寄与しています。さらに、各国の行政機関は、薬物障害を持つ 促進要因を検出するために、道路脇で定期的に口腔液のスクリーニングを実施する取り組みを行っています。また、重度の中毒者や薬物乱用に苦しむ人々を支援するために、薬物乱用・中毒プログラムを立ち上げています。さらに、薬物の密売人や地元の販売業者が増加し、薬物中毒者に薬物を簡単に提供するようになってきています。また、従来の金融システムとは一線を画す仮想通貨の利用が増加し、世界中の薬物ディーラーやバイヤーに匿名性の向上が認められていることも、市場の成長を後押ししています。

本レポートで回答した主な質問

  • 2022年の世界の薬物スクリーニング市場の規模は?
  • 2023年~2028年の世界の薬物スクリーニング市場の予想成長率はどのくらいか?
  • 世界の薬物スクリーニング市場を牽引する主要因は何か?
  • COVID-19が世界の薬物スクリーニング市場に与えた影響は?
  • 製品・サービスに基づく世界の薬物スクリーニング市場の内訳は?
  • サンプルタイプに基づく薬物スクリーニングの世界市場の内訳は?
  • エンドユーザーに基づく薬物スクリーニングの世界市場の内訳は?
  • 薬物スクリーニングの世界市場における主要地域はどこか?
  • 薬物スクリーニングの世界市場における主要プレイヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者について
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の薬物スクリーニング市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 製品・サービス別市場内訳

  • 機器別
    • 市場動向
    • 主要セグメント
      • イムノアッセイ・アナライザー
      • クロマトグラフィー装置
      • ブレスアナライザー
    • 市場予測
  • 迅速検査装置
    • 市場動向
    • 主要セグメント
      • 尿検査機器
      • 口腔内液検査装置
    • 市場予測
  • 消耗品
    • 市場動向
    • 主要セグメント
      • アッセイキット
      • サンプルコレクションカップ
      • キャリブレーター&コントロール
      • その他
    • 市場予測
  • ラボラトリーサービス
    • 市場動向
    • 市場予測

第7章 サンプルタイプ別市場内訳

  • 尿サンプル
    • 市場動向
    • 市場予測
  • 呼気サンプル
    • 市場動向
    • 市場予測
  • 口腔内液サンプル
    • 市場動向
    • 市場予測
  • 毛髪サンプル
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 エンドユーザー別市場内訳

  • 病院
    • 市場動向
    • 市場予測
  • 薬物検査ラボラトリー
    • 市場動向
    • 市場予測
  • ワークプレイス
    • 市場動向
    • 市場予測
  • 薬物治療センター
    • 市場動向
    • 市場予測
  • 疼痛管理センター
    • 市場動向
    • 市場予測
  • パーソナルユーザー
    • 市場動向
    • 市場予測
  • 刑事司法制度・法執行機関
    • 市場動向
    • 市場予測

第9章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Alfa Scientific Designs Inc.
    • Bio-Rad Laboratories Inc.
    • Dragerwerk AG & Co. KGaA
    • Laboratory Corporation of America Holdings
    • Lifeloc Technologies Inc.
    • Omega Laboratories Inc.
    • OraSure Technologies Inc.
    • Psychemedics Corporation
    • Quest Diagnostics Incorporated
    • Siemens AG
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Drug Screening Market: Major Drivers and Challenges
  • Figure 2: Global: Drug Screening Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Drug Screening Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Drug Screening Market: Breakup by Product and Service (in %), 2022
  • Figure 5: Global: Drug Screening Market: Breakup by Sample Type (in %), 2022
  • Figure 6: Global: Drug Screening Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Drug Screening Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Drug Screening (Equipment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Drug Screening (Equipment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Drug Screening (Rapid Testing Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Drug Screening (Rapid Testing Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Drug Screening (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Drug Screening (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Drug Screening (Laboratory Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Drug Screening (Laboratory Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Drug Screening (Urine Samples) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Drug Screening (Urine Samples) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Drug Screening (Breath Samples) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Drug Screening (Breath Samples) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Drug Screening (Oral Fluid Samples) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Drug Screening (Oral Fluid Samples) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Drug Screening (Hair Samples) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Drug Screening (Hair Samples) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Drug Screening (Other Sample Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Drug Screening (Other Sample Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Drug Screening (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Drug Screening (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Drug Screening (Drug Testing Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Drug Screening (Drug Testing Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Drug Screening (Workplaces) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Drug Screening (Workplaces) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Drug Screening (Drug Treatment Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Drug Screening (Drug Treatment Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Drug Screening (Pain Management Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Drug Screening (Pain Management Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Drug Screening (Personal Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Drug Screening (Personal Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Drug Screening (Criminal Justice System and Law Enforcement Agencies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Drug Screening (Criminal Justice System and Law Enforcement Agencies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: North America: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: North America: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: United States: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: United States: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Canada: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Canada: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Asia-Pacific: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Asia-Pacific: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: China: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: China: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Japan: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Japan: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: India: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: India: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: South Korea: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: South Korea: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Australia: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Australia: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Indonesia: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Indonesia: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Europe: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Europe: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Germany: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Germany: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: France: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: France: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: United Kingdom: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: United Kingdom: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Italy: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Italy: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Spain: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Spain: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Russia: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Russia: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Latin America: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Latin America: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Brazil: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Brazil: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Mexico: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Mexico: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Others: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Middle East and Africa: Drug Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Middle East and Africa: Drug Screening Market: Breakup by Country (in %), 2022
  • Figure 88: Middle East and Africa: Drug Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Global: Drug Screening Industry: SWOT Analysis
  • Figure 90: Global: Drug Screening Industry: Value Chain Analysis
  • Figure 91: Global: Drug Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug Screening Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Drug Screening Market Forecast: Breakup by Product and Service (in Million US$), 2023-2028
  • Table 3: Global: Drug Screening Market Forecast: Breakup by Sample Type (in Million US$), 2023-2028
  • Table 4: Global: Drug Screening Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Drug Screening Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Drug Screening Market: Competitive Structure
  • Table 7: Global: Drug Screening Market: Key Players
目次
Product Code: SR112023A5624

Market Overview:

The global drug screening market size reached US$ 6.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028. The growing number of drug traffickers and local dealers, rising cases of substance abuse, and increasing employment of virtual currencies represent some of the key factors driving the market.

Drug screening refers to the process of collecting and analyzing the blood, urine, hair, or saliva of an individual to detect the presence of contaminants and chemicals left behind due to drug usage. It comprises a wide variety of testing methods, such as enzyme immunoassays (IAs), gas chromatography (GC), and liquid chromatography/mass spectrometry (LC/MS), which is a superior and highly accurate drug confirmation test implemented on initial positive results. It is utilized for detecting the use and misuse of drugs, which includes illegal drugs, such as cocaine, heroin, and 3,4-Methylenedioxymethamphetamine (MDMA). It is also employed for detecting the misuse of various prescription medicines which are taken in a different way or in high doses. It is performed in various clinical trials of a drug to estimate the efficiency and safety of various novel drugs. Drug screening is also performed during legal prosecution for criminal law enforcement purposes. Furthermore, it is used in accessing abuse potential and adherence among various patients who are receiving opioid therapy.

Drug Screening Market Trends:

At present, the increasing demand for drug screening as it is accurate and provides spontaneous results represents one of the primary factors influencing the market positively. Besides this, rising cases of substance abuse around the world are propelling the growth of the market. In addition, the growing utilization of drugs among the masses to cope with losses, stress, and anxiety is offering a favorable market outlook. Apart from this, the rising trends of clubbing, drinking alcohol, smoking, and doing drugs among young individuals due to peer pressure is contributing to the growth of the market. Additionally, governing agencies of various countries are undertaking initiatives to carry out regular roadside oral fluid screening to detect drug-impaired drivers. They are also launching substance abuse and addiction programs to help severe addicts and individuals suffering from drug abuse. Moreover, there is a rise in the number of drug traffickers and local dealers providing easy access of drugs to addicts. This, coupled with the increasing employment of virtual currencies that operate beyond the traditional financial system, granting improved anonymity to drug dealers and buyers across the globe is supporting the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global drug screening market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and service, sample type and end user.

Product and Service Insights:

  • Equipment
    • Immunoassay Analyzers
    • Chromatography Instruments
    • Breath Analyzers
  • Rapid Testing Devices
    • Urine Testing Devices
    • Oral Fluid Testing Devices
  • Consumables
    • Assay Kits
    • Sample Collection Cups
    • Calibrators and Controls
    • Others
  • Laboratory Services

The report has provided a detailed breakup and analysis of the drug screening market based on the product and service. This includes equipment (immunoassay analyzers, chromatography instruments, and breath analyzers); rapid testing devices (urine testing devices and oral fluid testing devices); consumables (assay kits, sample collection cups, calibrators and controls, and others); and laboratory services. According to the report, rapid testing devices (urine testing devices and oral fluid testing devices) represented the largest segment.

Sample Type Insights:

  • Urine Samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Others

A detailed breakup and analysis of the drug screening market based on the sample type has also been provided in the report. This includes urine samples, breath samples, oral fluid samples, hair samples, and others. According to the report, urine samples accounted for the largest market share.

End User Insights:

  • Hospitals
  • Drug Testing Laboratories
  • Workplaces
  • Drug Treatment Centers
  • Pain Management Centers
  • Personal Users
  • Criminal Justice System and Law Enforcement Agencies

A detailed breakup and analysis of the drug screening market based on the end user has also been provided in the report. This includes hospitals, drug testing laboratories, workplaces, drug treatment centers, pain management centers, personal users, and criminal justice system and law enforcement agencies. According to the report, workplaces accounted for the largest market share.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for drug screening. Some of the factors driving the North America drug screening market included the growing cases of substance abusive, increasing number of drug dealers, rising black marketing of prescribed drugs, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global drug screening market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Dragerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc., Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • What was the size of the global drug screening market in 2022?
  • What is the expected growth rate of the global drug screening market during 2023-2028?
  • What are the key factors driving the global drug screening market?
  • What has been the impact of COVID-19 on the global drug screening market?
  • What is the breakup of the global drug screening market based on the product and service?
  • What is the breakup of the global drug screening market based on the sample type?
  • What is the breakup of the global drug screening market based on the end user?
  • What are the key regions in the global drug screening market?
  • Who are the key players/companies in the global drug screening market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Drug Screening Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Product and Service

  • 6.1  Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Immunoassay Analyzers
      • 6.1.2.2 Chromatography Instruments
      • 6.1.2.3 Breath Analyzers
    • 6.1.3 Market Forecast
  • 6.2  Rapid Testing Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Urine Testing Devices
      • 6.2.2.2 Oral Fluid Testing Devices
    • 6.2.3 Market Forecast
  • 6.3  Consumables
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Assay Kits
      • 6.3.2.2 Sample Collection Cups
      • 6.3.2.3 Calibrators and Controls
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast
  • 6.4  Laboratory Services
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7   Market Breakup by Sample Type

  • 7.1  Urine Samples
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Breath Samples
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Oral Fluid Samples
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Hair Samples
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5  Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8   Market Breakup by End User

  • 8.1  Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Drug Testing Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Workplaces
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4  Drug Treatment Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5  Pain Management Centers
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6  Personal Users
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7  Criminal Justice System and Law Enforcement Agencies
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2  Alfa Scientific Designs Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3  Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4  Dragerwerk AG & Co. KGaA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5  Laboratory Corporation of America Holdings
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6  Lifeloc Technologies Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7  Omega Laboratories Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8  OraSure Technologies Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9  Psychemedics Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10  Quest Diagnostics Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11  Siemens AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12  Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis